Document Type
Article
Publication Title
ACG Case Rep J
Abstract
Drug-induced pancreatitis (DIP) is a rare cause of pancreatitis with an extensive and growing list of offending medications. Drawing a causative relationship between a medication and pancreatitis can be challenging, requiring a thorough workup to exclude other potential etiologies. By using scoring systems to identify DIP, we have identified another case of suspected DIP. In this study, we present a case of pancreatitis 10 days after initiation of dupilumab. An evaluation for other causes was unrevealing. As dupilumab use increases, providers should be aware of this possible adverse effect.
First Page
01106
Last Page
01106
DOI
10.14309/crj.0000000000001106
Publication Date
7-1-2023
Recommended Citation
Jasti VV, McCarthy ST, Govani SM. Dupilumab-Induced Pancreatitis. ACG Case Rep J. 2023 Jul 21;10(7):e01106. doi: 10.14309/crj.0000000000001106. PMID: 37492485; PMCID: PMC10365188.